"New Drugs on the Horizon"
This annual symposium features the first disclosure of the chemistry and biology of new drug candidates which are either nearing clinical development or have entered clinical trials.
Sunday, April 18, 2010
3:15 p.m. to 5:15 p.m.
Room 207, Walter E. Washington Convention Center
Co-Chairpersons: Dr. Lori S. Friedman, Director, Cancer Signaling & Translational Oncology at Genentech, Inc.
Dr. Matthew Marx, Associate Research Fellow at Pfizer, Inc.
| Francesco Colatta |
Sunday, April 18, 2010 3:15 p.m. to 3:40 p.m. |
| Gabriele M. Schaefer |
Sunday, April 18, 2010 3:45 p.m. to 4:10 p.m. |
| Masuo Yamaoka |
Sunday, April 18, 2010 4:15 p.m. to 4:40 p.m. |
| William R. Sellers |
Sunday, April 18, 2010 4:45 p.m. to 5:10 p.m. |
AACR Award for Outstanding Achievement in Chemistry in Cancer Research Lecture
Tuesday, April 21, 2010
3:00 p.m. - 4:00 p.m.
Room 202, Walter E. Washington Convention Center
Stuart L. Schreiber, Ph.D.
Broad Institute of Harvard and MIT
Morris Loeb Professor, Harvard University
Investigator, Howard Hughes Medical Institute
"Small-Molecule Probes of Cancer Biology"
CICR Town Meeting and Networking Reception
Sunday, April 18, 2010
5:30 p.m. - 7:30 p.m.
Room TBD, Washington Grand Hyatt
Speakers: Chairperson, Laurence H. Hurley; Chairperson-elect, Peter C. Dedon
All interested Annual Meeting registrants are invited to attend this event, which provides an opportunity to raise questions and contribute ideas to help shape future Working Group initiatives.
Career Paths in Cancer Drug Development, presented by the Young Chemists Committee
Monday, April 19, 2010
5:30 p.m. - 7:30 p.m.
Room TBD, Washington Grand Hyatt
Chairpersons: Drs. Erin Prestwich, Ph.D., MIT, and Danzhou Yang, Ph.D., University of Arizona College of Pharmacy
All Professional Advancement Sessions are presented at no additional charge for AACR members; non-members pay a nominal registration fee of $50 for each session. Pre-registration is required for all sessions. More information will be available as the meeting approaches. Learn more about the AACR 101st Annual Meeting 2010.
During this session, attendees will explore different careers paths for scientists wanting to contribute to cancer research through cancer drug development and the opportunities in those paths including issues of intellectual property, funding, and gaining and retaining employment in various settings. A keynote address followed by a panel discussion led by some of the most prominent chemically oriented cancer researchers will be followed by roundtable discussions broaching the following possible topics: funding; career planning, training and intellectual property. At the end of the session, attendees should be more aware of the avenues of employment open to them as scientists in cancer drug development. They should feel more confident about career prospects and how to succeed in their chosen path. Open to all Annual Meeting attendees.